MARKET

RGEN

RGEN

Repligen
NASDAQ
176.27
-5.76
-3.16%
After Hours: 181.00 +4.73 +2.68% 19:30 08/28 EDT
OPEN
179.76
PREV CLOSE
182.03
HIGH
181.35
LOW
175.70
VOLUME
818.72K
TURNOVER
--
52 WEEK HIGH
188.73
52 WEEK LOW
100.99
MARKET CAP
9.95B
P/E (TTM)
240.25
1D
5D
1M
3M
1Y
5Y
1D
Repligen (RGEN) Dropped, So What Is Behind The Latest Attention?
Simply Wall St · 11h ago
Why Is Viking Therapeutics (VKTX) Up 2.3% Since Last Earnings Report?
NASDAQ · 1d ago
Will Stronger 2026 Guidance and Broad-Based Growth Change Repligen's (RGEN) Narrative
Simply Wall St · 1d ago
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
NASDAQ · 2d ago
5 Biotech Stocks Worth Adding to Your Portfolio Now
NASDAQ · 3d ago
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Barchart · 3d ago
J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
NASDAQ · 4d ago
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
NASDAQ · 5d ago
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.